Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report
Key Clinical Message Acquired thrombotic thrombocytopenic purpura is a life‐threatening condition that rarely presents during pregnancy. Early diagnosis and treatment with plasma exchange is needed to achieve a good pregnancy outcome.
Main Authors: | Javier Arzuaga‐Mendez, Maite Moreno, Juan J. Mateos‐Mazón, Miriam Vara, Marta Dueñas, Rafael A. Del Orbe, Elena Amutio, Beatriz Arrizabalaga, Juan C. García‐Ruiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3752 |
Similar Items
-
Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura with Rituximab, a Monoclonal Antibody: a Case Report
by: M Pedram, et al.
Published: (2009-09-01) -
Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with Rituximab
by: Nishant Poddar, et al.
Published: (2013-01-01) -
Vaccination and Thrombotic Thrombocytopenic Purpura
by: İrfan Yavaşoğlu
Published: (2020-08-01) -
Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
by: Pooja Sikka, et al.
Published: (2013-01-01) -
Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura - a case report and concise review of the literature
by: D Brodmann
Published: (2007-09-01)